L
Lixil Corp
TSE:5938
Lixil Corp
TSE:5938
Price:
1 725.5
JPY
-0.26%
Market Closed
Market Cap:
495.8B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Lixil Corp
1725.5
-4.5 (-0.26%)
| 52 Week Range |
1 569
2 008
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Lixil Corp
Balance Sheet
Balance Sheet Decomposition
Lixil Corp
Lixil Corp
| Current Assets | 684.4B |
| Cash & Short-Term Investments | 114.9B |
| Receivables | 297.8B |
| Other Current Assets | 271.7B |
| Non-Current Assets | 1.1T |
| Long-Term Investments | 68.7B |
| PP&E | 430B |
| Intangibles | 544.8B |
| Other Non-Current Assets | 86.8B |
| Current Liabilities | 551.1B |
| Accounts Payable | 238B |
| Other Current Liabilities | 313.1B |
| Non-Current Liabilities | 652B |
| Long-Term Debt | 455.6B |
| Other Non-Current Liabilities | 196.4B |
Balance Sheet
Lixil Corp
Lixil Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
147 708
|
129 646
|
121 563
|
138 751
|
141 421
|
95 862
|
111 061
|
100 404
|
106 677
|
124 485
|
|
| Cash Equivalents |
147 708
|
129 646
|
121 563
|
138 751
|
141 421
|
95 862
|
111 061
|
100 404
|
106 677
|
124 485
|
|
| Short-Term Investments |
108 004
|
30 004
|
12 217
|
5 577
|
12 612
|
9 875
|
10 669
|
17 842
|
18 864
|
11 402
|
|
| Total Receivables |
508 122
|
483 209
|
486 831
|
355 075
|
465 494
|
329 074
|
311 795
|
300 740
|
314 838
|
322 977
|
|
| Accounts Receivables |
490 700
|
459 270
|
460 160
|
338 653
|
448 241
|
316 749
|
289 413
|
291 245
|
303 120
|
309 173
|
|
| Other Receivables |
17 422
|
23 939
|
26 671
|
16 422
|
17 253
|
12 325
|
22 382
|
9 495
|
11 718
|
13 804
|
|
| Inventory |
218 028
|
211 855
|
204 581
|
217 904
|
234 646
|
227 606
|
180 417
|
237 927
|
276 645
|
248 300
|
|
| Other Current Assets |
21 343
|
30 504
|
24 591
|
195 469
|
37 607
|
80 363
|
23 831
|
57 694
|
27 509
|
23 614
|
|
| Total Current Assets |
1 003 205
|
885 218
|
849 783
|
912 776
|
891 780
|
742 780
|
637 773
|
714 607
|
744 533
|
730 778
|
|
| PP&E Net |
528 946
|
546 575
|
538 137
|
542 330
|
552 759
|
711 885
|
465 086
|
427 324
|
440 066
|
438 675
|
|
| PP&E Gross |
528 946
|
546 575
|
538 137
|
542 330
|
552 759
|
711 885
|
465 086
|
427 324
|
440 066
|
438 675
|
|
| Accumulated Depreciation |
680 188
|
690 563
|
697 686
|
697 134
|
750 416
|
738 343
|
714 080
|
728 112
|
752 023
|
783 205
|
|
| Intangible Assets |
89 082
|
305 847
|
289 981
|
291 277
|
276 183
|
260 664
|
270 968
|
277 210
|
297 633
|
327 106
|
|
| Goodwill |
56 075
|
195 478
|
184 334
|
185 362
|
180 899
|
173 438
|
182 488
|
194 093
|
210 099
|
234 367
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
167 164
|
123 576
|
126 333
|
122 439
|
109 187
|
108 234
|
98 882
|
77 105
|
65 375
|
69 491
|
|
| Other Long-Term Assets |
70 955
|
73 426
|
53 597
|
52 947
|
48 736
|
94 528
|
86 617
|
92 543
|
95 828
|
86 178
|
|
| Other Assets |
56 075
|
195 478
|
184 334
|
185 362
|
180 899
|
173 438
|
182 488
|
194 093
|
210 099
|
234 367
|
|
| Total Assets |
1 915 427
N/A
|
2 130 120
+11%
|
2 042 165
-4%
|
2 107 131
+3%
|
2 059 544
-2%
|
2 091 529
+2%
|
1 741 814
-17%
|
1 782 882
+2%
|
1 853 534
+4%
|
1 886 595
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
225 315
|
217 275
|
222 167
|
211 141
|
266 078
|
208 044
|
173 622
|
214 378
|
205 262
|
396 441
|
|
| Accrued Liabilities |
60 036
|
69 542
|
77 663
|
76 762
|
76 422
|
72 089
|
54 113
|
48 779
|
47 376
|
45 266
|
|
| Short-Term Debt |
154 942
|
206 101
|
158 989
|
144 262
|
203 472
|
142 183
|
59 865
|
89 563
|
92 568
|
123 749
|
|
| Current Portion of Long-Term Debt |
70 214
|
119 559
|
92 337
|
98 728
|
164 502
|
125 194
|
121 678
|
60 147
|
135 152
|
104 612
|
|
| Other Current Liabilities |
205 342
|
250 001
|
226 029
|
293 254
|
228 178
|
259 630
|
177 650
|
190 134
|
171 844
|
173 324
|
|
| Total Current Liabilities |
715 849
|
862 478
|
777 185
|
824 147
|
938 652
|
807 140
|
586 928
|
603 001
|
652 202
|
594 592
|
|
| Long-Term Debt |
482 523
|
501 399
|
508 582
|
444 920
|
357 984
|
565 174
|
413 962
|
374 993
|
390 680
|
448 831
|
|
| Deferred Income Tax |
27 022
|
81 045
|
73 437
|
62 698
|
60 572
|
55 200
|
56 468
|
61 875
|
66 685
|
73 716
|
|
| Minority Interest |
7 108
|
12 502
|
12 187
|
32 676
|
33 511
|
32 972
|
2 496
|
2 583
|
2 287
|
1 827
|
|
| Other Liabilities |
99 178
|
147 890
|
123 530
|
125 793
|
135 169
|
128 878
|
129 689
|
128 045
|
116 247
|
125 118
|
|
| Total Liabilities |
1 331 680
N/A
|
1 605 314
+21%
|
1 494 921
-7%
|
1 490 234
0%
|
1 525 888
+2%
|
1 589 364
+4%
|
1 189 543
-25%
|
1 170 497
-2%
|
1 228 101
+5%
|
1 244 084
+1%
|
|
| Equity | |||||||||||
| Common Stock |
68 121
|
68 121
|
68 121
|
68 121
|
68 418
|
68 418
|
68 418
|
68 418
|
68 418
|
68 530
|
|
| Retained Earnings |
271 643
|
227 768
|
256 724
|
292 797
|
222 095
|
217 206
|
233 808
|
267 920
|
267 162
|
226 897
|
|
| Additional Paid In Capital |
261 166
|
261 024
|
260 901
|
277 753
|
277 584
|
278 120
|
278 240
|
278 635
|
221 812
|
221 632
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
56 205
|
54 898
|
53 362
|
48 984
|
48 899
|
48 870
|
48 610
|
47 542
|
113
|
126
|
|
| Other Equity |
39 022
|
22 791
|
14 860
|
27 210
|
14 458
|
12 709
|
20 415
|
44 954
|
68 154
|
125 578
|
|
| Total Equity |
583 747
N/A
|
524 806
-10%
|
547 244
+4%
|
616 897
+13%
|
533 656
-13%
|
502 165
-6%
|
552 271
+10%
|
612 385
+11%
|
625 433
+2%
|
642 511
+3%
|
|
| Total Liabilities & Equity |
1 915 427
N/A
|
2 130 120
+11%
|
2 042 165
-4%
|
2 107 131
+3%
|
2 059 544
-2%
|
2 091 529
+2%
|
1 741 814
-17%
|
1 782 882
+2%
|
1 853 534
+4%
|
1 886 595
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
286
|
287
|
288
|
290
|
290
|
290
|
290
|
291
|
287
|
287
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
